The owner, Issy, told Newsweek she first experienced a seizure at home in November 2024, and has since noticed her cat ...

UCB shares 21 scientific abstracts, including the presentation of positive primary efficacy and safety results from a phase 3 study of FINTEPLA ® (fenfluramine) 1 in CDD, marking the third ...

Headaches could be more than just an inconvenience; they may indicate underlying brain health issues that could escalate into ...

A generous donor has pledged to match up to $1,000,000 in fundraising dollars to sustain Baking Memories 4 Kids and ensure ...

Epiminder plans to launch its GO Minder system in the US during the first half of 2026 using funds from the IPO, which raised ...

A New York accountant alleges her employer mishandled her epilepsy and medical leave, then terminated her after she sought ...

Neuroscientists at UNLV said a CBD-like compound is reducing seizures in mice and could become a brand-new, safer alternative ...

The EMBOLD topline results will be presented at the American Epilepsy Society Annual Meeting at the Georgia World Congress Center, Poster Hall B2, 1.38 from 12:00-2:00 p.m. on Saturday, December 6, ...

If headaches are accompanied by other things like vomiting or forgetfulness, then it may point to underlying issues.

Eight scientific posters demonstrate significant seizure reduction and improved outcomes with VNS Therapy in patients with ...

Melbourne-based Epiminder plans to use the funds from its initial public offering to commercialise a device it says could ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...